Peaches Biotech is investing €6.8 million in a new secretome platform study, with phases I and II ending this year and the final phase starting in...
Peaches Biotech is specialized in the creation of medicines based on advanced therapies, especially with cytokines, stem cells, or T-lymphocytes, which will allow patients to take...
Peaches Biotech is a company specializing in the creation of medicines based on advanced therapies, especially with cytokines, stem cells, or T-lymphocytes, which will allow patients...